CA2826890A1 - Compositions et procedes d'amelioration de pronostic d'un etre humain souffrant d'hemorragie sous arachnoidienne - Google Patents

Compositions et procedes d'amelioration de pronostic d'un etre humain souffrant d'hemorragie sous arachnoidienne Download PDF

Info

Publication number
CA2826890A1
CA2826890A1 CA2826890A CA2826890A CA2826890A1 CA 2826890 A1 CA2826890 A1 CA 2826890A1 CA 2826890 A CA2826890 A CA 2826890A CA 2826890 A CA2826890 A CA 2826890A CA 2826890 A1 CA2826890 A1 CA 2826890A1
Authority
CA
Canada
Prior art keywords
less
calcium channel
voltage
channel blocker
gated calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2826890A
Other languages
English (en)
Inventor
Brian A. Leuthner
R. Loch Macdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PDS Biotechnology Corp
Original Assignee
Edge Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edge Therapeutics Inc filed Critical Edge Therapeutics Inc
Priority claimed from PCT/US2012/024893 external-priority patent/WO2012109664A1/fr
Publication of CA2826890A1 publication Critical patent/CA2826890A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une composition pharmaceutique, un système d'administration et un procédé pour traiter une complication retardée, associée à une lésion cérébrale chez un mammifère, et pour améliorer son pronostic par l'implantation d'une quantité thérapeutiquement efficace de la composition pharmaceutique, contenant un bloqueur des canaux calciques voltage-dépendants, et d'un support de qualité pharmaceutique dans un emplacement prédéterminé dans le cerveau, ce qui réduit les signes ou les symptômes d'au moins une complication retardée, associée à la lésion cérébrale.
CA2826890A 2011-02-11 2012-02-13 Compositions et procedes d'amelioration de pronostic d'un etre humain souffrant d'hemorragie sous arachnoidienne Abandoned CA2826890A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/441,695 2011-02-11
PCT/US2012/024893 WO2012109664A1 (fr) 2011-02-11 2012-02-13 Compositions et procédés d'amélioration de pronostic d'un être humain souffrant d'hémorragie sous arachnoïdienne

Publications (1)

Publication Number Publication Date
CA2826890A1 true CA2826890A1 (fr) 2012-08-16

Family

ID=49221650

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2826890A Abandoned CA2826890A1 (fr) 2011-02-11 2012-02-13 Compositions et procedes d'amelioration de pronostic d'un etre humain souffrant d'hemorragie sous arachnoidienne

Country Status (1)

Country Link
CA (1) CA2826890A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110354120A (zh) * 2018-03-26 2019-10-22 广州白云山中一药业有限公司 普罗托品或其盐在制备防治脑血管疾病药物中的应用
CN116437899A (zh) * 2020-09-09 2023-07-14 意大利国家研究委员会 用于递送治疗性/诊断性化合物的基于包埋纳米颗粒的微粒的粉末组合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110354120A (zh) * 2018-03-26 2019-10-22 广州白云山中一药业有限公司 普罗托品或其盐在制备防治脑血管疾病药物中的应用
CN116437899A (zh) * 2020-09-09 2023-07-14 意大利国家研究委员会 用于递送治疗性/诊断性化合物的基于包埋纳米颗粒的微粒的粉末组合物

Similar Documents

Publication Publication Date Title
AU2012240131B2 (en) Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
EP2164497B1 (fr) Système d'administration d'un médicament pour la prévention d'un angiospasme cérébral
Wang et al. Facile nose-to-brain delivery of rotigotine-loaded polymer micelles thermosensitive hydrogels: In vitro characterization and in vivo behavior study
AU2012214137B2 (en) Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage
AU2016201681B2 (en) A drug delivery system for the prevention of cerebral vasospasm
NZ613970B2 (en) Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage
AU2013203192B2 (en) A drug delivery system for the prevention of cerebral vasospasm
NZ714032B2 (en) Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
NZ727856B2 (en) Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
NZ616458B2 (en) Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
HK1230079A1 (en) Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161215

FZDE Discontinued

Effective date: 20190709